ASSURE vs. S-TRAC: conflicting results of adjuvant treatments for kidney cancer in the era of targeted agents and genomics.

ABSTRACT:

SUBMITTER: Porta C 

PROVIDER: S-EPMC5104625 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature